Sort   by:  
 Page size 
UnknownTelomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study.
Not available
S-EPMC4712332 | biostudies-literature
UnknownPredicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer.
Not available
S-EPMC8113167 | biostudies-literature
UnknownUnveiling the Interplay Between Dendritic Cells and Natural Killer Cells as Key Players in <i>Leishmania</i> Infection.
Not available
S-EPMC11832263 | biostudies-literature
UnknownPhase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.
Not available
S-EPMC5294485 | biostudies-literature
UnknownPatients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?
Not available
S-EPMC9865729 | biostudies-literature
UnknownValidation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Not available
S-EPMC10618649 | biostudies-literature
UnknownMaintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial.
Not available
S-EPMC12381027 | biostudies-literature
UnknownSTK38 kinase acts as XPO1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoes
Not available
S-SCDT-EMBOR-2019-48150V1 | biostudies-other
UnknownImmunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Not available
S-EPMC10867612 | biostudies-literature
UnknownClassification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysis.
Not available
S-EPMC12318041 | biostudies-literature
Sort   by:  
 Page size